GSA Capital Partners’s UroGen Pharma URGN Stock Holding History

GSA Capital Partners’s Portfolio URGN Stock Details URGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-48,964	Closed	-$977K	–	2107
2025 Q3	$977K	Buy	+48,964	New	+$879K	0.08%	417
2024 Q4	–	Sell	-19,597	Closed	-$249K	–	2050
2024 Q3	$249K	Buy	+19,597	New	+$291K	0.02%	1320
2024 Q2	–	Sell	-14,937	Closed	-$224K	–	2043
2024 Q1	$224K	Buy	+14,937	New	+$244K	0.02%	1358
2023 Q4	–	Sell	-10,189	Closed	-$143K	–	1956
2023 Q3	$143K	Buy	+10,189	New	+$164K	0.01%	1349
2023 Q1	–	Sell	-31,046	Closed	-$275K	–	1953
2022 Q4	$275K	Sell	31,046 -18,176	-37%	-$172K	0.03%	993
2022 Q3	$410K	Buy	49,222 +951	+2%	+$7.87K	0.05%	723
2022 Q2	$395K	Sell	48,271 -8,953	-16%	-$61.5K	0.06%	650
2022 Q1	$498K	Buy	57,224 +18,160	+46%	+$142K	0.07%	536
2021 Q4	$371K	Buy	39,064 +18,559	+91%	+$262K	0.05%	794
2021 Q3	$345K	Sell	20,505 -7,378	-26%	-$117K	0.04%	921
2021 Q2	$426K	Buy	27,883 +4,339	+18%	+$78.5K	0.05%	734
2021 Q1	$459K	Buy	+23,544	New	+$500K	0.08%	401
2018 Q1	–	Sell	-10,200	Closed	-$380K	–	1840
2017 Q4	$380K	Buy	10,200 +900	+10%	+$32K	0.02%	1090
2017 Q3	$293K	Buy	+9,300	New	+$205K	0.02%	1265

Other funds holding URGN

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jefferies Financial Group New York $8.2B AUM 40.95% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

SG Americas Securities

SG Americas Securities New York $90.6B AUM 36.98% 1-Year Est. Return

American Century Companies

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return